Business Context and Reporting Period
Northrop Grumman Corporation filed its Form 10-K for the fiscal year ended December 31, 2020, including fourth-quarter results. The company is a global aerospace and defense contractor serving primarily the U.S. government, Department of Defense and intelligence community. Reportable segments are Aeronautics Systems, Defense Systems, Mission Systems and Space Systems.
Effective January 1, 2020, the company realigned its sectors and retrospectively revised segment information. In December 2020, it agreed to sell its IT and mission support services business for $3.4 billion in cash, subject to regulatory approval and customary closing conditions. The transaction was expected to close in the first quarter of 2021.
Key Financial Metrics
| Metric | 2020 | 2019 | Change |
|---|---|---|---|
| Sales | $36.799 billion | $33.841 billion | Up 9% |
| Operating income | $4.065 billion | $3.969 billion | Up 2% |
| Operating margin | 11.0% | 11.7% | Down 70 bps |
| Net earnings | $3.189 billion | $2.248 billion | Up 42% |
| Diluted EPS | $19.03 | $13.22 | Up 44% |
| Net cash from operations | $4.305 billion | $4.297 billion | Comparable |
| Adjusted free cash flow | $3.683 billion | $3.128 billion | Up 18% |
| Cash and cash equivalents | $4.907 billion | $2.245 billion | Up $2.662 billion |
| Total debt | $15.003 billion | $13.879 billion | Up $1.124 billion |
| Total backlog | $80.969 billion | $64.840 billion | Up 25% |
Net earnings benefited from a lower after-tax mark-to-market pension and other postretirement benefit expense. Excluding this item, MTM-adjusted net earnings were $3.963 billion, up 10%, and MTM-adjusted diluted EPS was $23.65, up 12%.
The effective tax rate increased to 14.5% from 11.8%. Company-sponsored research and development expense was $1.073 billion, or 2.9% of sales. U.S. government sales represented 84% of total sales, compared with 83% in 2019; fixed-price and cost-type contracts each represented approximately half of external sales.
Segment Performance
| Segment | 2020 Sales | Sales Change | 2020 Operating Margin |
|---|---|---|---|
| Aeronautics Systems | $12.169 billion | Up 9% | 9.9% |
| Defense Systems | $7.543 billion | Up 1% | 11.2% |
| Mission Systems | $10.080 billion | Up 7% | 14.5% |
| Space Systems | $8.744 billion | Up 18% | 10.2% |
Space Systems was the fastest-growing segment, supported by restricted programs, Next Generation OPIR, NASA Artemis, Ground Based Strategic Deterrent, launch vehicles and hypersonics. Aeronautics Systems margin declined primarily because of lower estimate-at-completion adjustments and a $444 million restricted-program equipment sale that was dilutive to segment margin.
Material Changes Versus the Prior Comparable Period
- Sales increased $2.958 billion, while operating income increased only $96 million, resulting in lower consolidated and segment margin rates.
- Net earnings increased $941 million, principally because after-tax MTM pension expense declined by $584 million.
- Operating cash flow remained broadly stable despite a $750 million discretionary pretax pension contribution, compared with $120 million in 2019.
- Adjusted free cash flow increased by $555 million, including $205 million of proceeds related to the sale of equipment to a customer and the after-tax effect of discretionary pension contributions.
- The company issued $2.25 billion of senior notes in March 2020 and repaid $1.0 billion of senior notes at maturity in October. No commercial paper or revolving credit facility borrowings were outstanding at year-end.
- Backlog increased $16.129 billion, driven in part by $52.9 billion of net awards, including $13.3 billion for Ground Based Strategic Deterrent and $17.4 billion for restricted programs.
- Fourth-quarter 2020 sales were $10.212 billion, operating income was $1.152 billion, net earnings were $330 million and diluted EPS was $1.97. Fourth-quarter 2019 net earnings were a $409 million loss, although the filing does not provide a detailed quarter-specific explanation in the supplied text.
Guidance, Outlook, Risks and Unusual Items
The filing does not provide a clear numerical 2021 sales, margin, EPS or cash-flow guidance figure. Management expects cash on hand, operating cash flow and available financing sources to be sufficient to fund operations for at least the next 12 months. Approximately 40% of year-end backlog was expected to convert to revenue over the following 12 months and approximately 60% over the following 24 months.
Management stated that COVID-19 did not significantly affect overall 2020 revenue or operating income, but it increased operating costs, absenteeism, productivity pressure and supply-chain risk. Recovery of certain COVID-19 costs under the CARES Act and customer contract provisions remained uncertain.
- Customer concentration and reliance on U.S. defense appropriations expose results to changes in government priorities, funding delays, continuing resolutions, cancellations and termination rights.
- Approximately half of sales were under fixed-price contracts, creating exposure to cost growth, technical issues, schedule delays and supplier performance.
- Contract accounting depends on estimates of revenue, costs, incentives and claims. Aggregate net favorable estimate-at-completion adjustments contributed $466 million to 2020 operating income.
- Bethpage, New York environmental remediation remains a significant contingency. Accrued environmental costs were $614 million, with $346 million of reasonably possible future costs in excess of accrued amounts; potential cumulative outcomes for Bethpage could not be reasonably estimated.
- The company is contesting U.S. government concerns regarding interest-rate assumptions used in CAS pension accounting. Management stated that the matter could have a material adverse effect, but no loss range was estimable.
- The company faces litigation concerning a former U.S. Postal Service contract; the potential outcome could not be predicted or reasonably estimated.
- Unrecognized tax benefits increased to $1.481 billion, including accrued interest and penalties, and tax examinations and appeals remain ongoing.
- The company reported no goodwill impairment, no significant off-balance-sheet arrangements and effective internal control over financial reporting. Deloitte issued unqualified opinions on the financial statements and internal controls.
Important Facts for Investors to Verify
- Completion, proceeds and post-closing financial effects of the planned $3.4 billion IT and mission support services divestiture.
- Conversion, funding status and timing of the $80.969 billion backlog, including the large unfunded Space Systems balance.
- Future margin performance, particularly in Aeronautics Systems and Space Systems, and the sustainability of estimate-at-completion benefits.
- Cash deployment priorities, including the $5.8 billion total share-repurchase authorization and dividend policy.
- Debt maturities, pension funding requirements and sensitivity to discount rates and investment returns.
- Potential exposure from Bethpage remediation, CAS pension cost claims, tax audits, litigation and COVID-19 cost recovery.
- Impact of U.S. defense budgets, appropriations and acquisition priorities on major programs and future awards.